investigational car t-cell therapy in relapsed/refractory multiple myeloma
Published 4 years ago • 106 plays • Length 6:58Download video MP4
Download video MP3
Similar videos
-
7:13
treating relapsed/refractory multiple myeloma with car t-cell therapy
-
1:12
evaluating the role of car t-cell therapy in relapsed/refractory dlbcl
-
3:47
what is car t-cell therapy?
-
1:17
dr. hari on car t-cell therapy in relapsed/refractory multiple myeloma
-
1:39
dr. galal on car t-cell therapy in relapsed/refractory lymphomas
-
8:22
case 4: bcma-targeted car t-cell therapy in myeloma
-
2:17
dr hernandez-ilizaliturri on the use of car t-cell therapy in r/r multiple myeloma
-
34:45
relapsed/refractory multiple myeloma and car t-cell therapy: navigating the patient journey
-
3:35
bcma-directed car t-cell therapy: outlook
-
3:07
case 4: molecular testing and car t-cell therapy in myeloma
-
1:12
causes for relapse in multiple myeloma with car t cells
-
10:18
ide-cel; bb2121, a bcma-targeted car t-cell therapy, in patients with rrmm: initial karmma results
-
4:06
case 4: car t-cell therapy in myeloma
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
2:02
dr. voorhees on the role of car t-cell therapy in multiple myeloma
-
4:17
car-t cell therapy cilta-cel for relapsed/refractory myeloma | doris hansen, md | asco 2023
-
4:17
clinical outcomes of relapsed/refractory multiple myeloma patients after bcma-targeted car t the...
-
2:21
the potential of cs1-targeted car-t therapy in multiple myeloma
-
1:40
dr. wong on investigational car t-cell products in multiple myeloma